Very good sign that IVAC will move substantially higher in the near future. IVAC moving up in a down market means company earnings very strong in near future.
good explanation. thanks.
So somebody is not afraid of owning 400,000 shares at $5 per stock share
IVAC161021P00005000) -OPR 0ptions
0.45 0.00(0.00%) 11:04AM EDT
0.45 - 0.45
N/A - N/A
Sentiment: Strong Buy
Short puts lock in a price where investors must buy a stock, while letting them collect premium. Traders use the technique when they like a stock and think the risk of a big drop is limited.
If the overall stock market takes a run up, IVAC could see $11.00 per share. Interest rates probably not going to change until December 2016 so stock market should run up.
Hilary is the ultimate nightmare waiting to happen. With her as President, we will all be eating out of trash cans within four years because she will bankrupt the USA. Trump will win the Presidency.
Flash Boys high volume legal frontrunners have manipulated the market again to take massive positions in Allergan for their clients. Allergan will be rising when they are done.
Allergan plc Ordinary Shares (NYSE:AGN) shares traded -1.91% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $296.81 within the next 52-weeks. Since analyst price targets calculations are subjective, there often can be a wide range of targets from various analysts.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have high price target of $400.00 and with a conservative view have low price target of $238.00 based on 16 opinions, anyhow if seeing it from optimistic overview then it has a 90 percent upside potential from the latest closing price ...
TEVA deal giving AGN 40 Billion dollars should go through in July 2016 and AGN price should return to $280 to $300 per share
Sentiment: Strong Buy
Check the stats
Well the stock share price is rising and the TEVA deal is on track so I guess we are going higher.
sorry Pfizer is out to the deal, put they are paying Allergan 160 million dollars to walk away. A good Payday for Allergan
Somebody sacrificed 500 shares at the end of the day to knock the ASTC price down to $2.10. They did this so they can pick up another 100,000 shares tomorrow. Smart people are buying.
The unaffected Allergan price prior to the announced Pfizer acquisition implied a multiple of 16-17x. Although Pfizer announced a purchase price that accorded a 19x multiple, we'll disregard that as most acquisitions require a control premium. Prior to the Merger though, Allergan did not have much, if any, takeover premium. It was trading historically in-line with its multiple and as such, the 16-17x is a fair indication of the multiple Allergan would have enjoyed as a standalone company.